Although it has been demonstrated that individuals with GH deficiency and compromised quality of life may benefit from GH replacement therapy16, the relationship between quality of life and GH deficiency in POTS is complex and warrants in-depth research. The gene discussed is GH1; the disease is postural orthostatic tachycardia syndrome.